Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets

References

• Samani SM, Montaseri H, Kazemi A. (2003). The effect of polymer blends on the release profiles of diclofenac sodium from matrices. Eur J Pharm Biopharm, 55:351–5.
   PubMed Web of Science ®Google Scholar
• Su S-F, Ch-H Chou, Ch-F Kung, Huang J-D. (2003). In vitro and in vivo comparison of two diclofenac sustained release oral formulations. Int J Pharm, 250:39–46.
   Google Scholar
• Savaser A, Őzkan Y, Ismer A. (2005). Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Il Farmaco, 60:171–7.
   PubMedGoogle Scholar
• Kincl M, Vrecer F, Veber M. (2004). Characterization of factors affecting the release of low-solubility from prolonged release tablets. Anal Chim Acta, 502:107–13.
   Web of Science ®Google Scholar
• Rajabi-Siahboomi AR, Melia CD. (1994). Identification of active molecular structures in thermally dependent release behaviour of diclofenac sodium from HPMC matrices. Proc Int Symp Contr Rel Bioact Mater, 21:25–6.
   Google Scholar
• Avachat A, Kotwal N. (2007). Design and evaluation of matrix-based release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech, 8(4):E88.
   PubMedGoogle Scholar
• Morkhade DM, Fulzele SV, Satturwar PM, Joshi SB. (2006). Gum copal and damar: Novel matrix forming materials for sustained drug delivery. Ind J Pharm Sci, 68:53–8.
   Google Scholar
• Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani S, Sharbafi J, Siahi-Shadbad MR. (2004). The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices. Il Farmaco, 59:819–25.
   PubMedGoogle Scholar
• Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. (1999). Influence of drug: Hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release, 57:75–85.
   PubMed Web of Science ®Google Scholar
• Heng PWS, Chan LW, Easterbrook MG, Xiaoman L. (2001). Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J Control Release, 76:39–49.
   PubMed Web of Science ®Google Scholar
• Mitchell SA, Balwinski K. (2007). Investigation of hypromellose particle size effect on drug release from sustained release hydrophilic matrix tablets. Drug Dev Ind Pharm, 33:952–8.
   PubMed Web of Science ®Google Scholar
• Liew CV, Chan LW, Ching AL, Heng PWS. (2006). Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm, 309:25–37.
   PubMed Web of Science ®Google Scholar
• Dvorácková K, Rabišková M, Masteiková R, Vocilková L. (2007). Thermoplastic granulation as an alternative to prepare hydrophilic-lipophilic matrix tablest. Ceska Slov Farm, 56:129–34.
   PubMedGoogle Scholar
• Vueba ML, Batista de Carvalho LAE, Veiga F, Sousa JJ, Pina ME. (2005). Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev Ind Pharm, 31:653–65.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. (1996). Mathematical comparison of dissolution profiles. Pharm Tech, 20:64–74.
   Google Scholar
• Eryol C, Demirtürk E, Öner L. (2004). Preparation of meloxicam tablet formulations and evaluation of in vitro release similarities. FABAD J Pharm Sci, 29:53–61.
   Google Scholar
• Ch Lu, Lu Y, Chen J, Zhang W, Wu W. (2007). Synchronized and sustained release of multiple component in silymarin from erodible glyceryl monostearate matrix tablet system. Eur J Pharm Biopharm, 66:210–9.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–33.
   PubMed Web of Science ®Google Scholar
• Perissutti B, Rubessa F, Moneghini M, Voinovich D. (2003). Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int J Pharm, 256:53–63.
   PubMed Web of Science ®Google Scholar
• Pereira de Souza T, Martínez-Pacheco R, Gómez-Amoza JL, Petrovick PR. (2007). Eudragit E as excipient for production of granules and tablets from phyllanthus niruri L spray-dried extract. AAPS PharmSciTech, 8(2) Article 34.
   PubMed Web of Science ®Google Scholar
• Farag Badawy SI, Lee TJ, Menning MM. (2000). Effect of drug substance particle size on the characteristics of granulation manufactured in a high-shear mixer. AAPS PharmSciTech, 1(4):E33.
   PubMedGoogle Scholar
• Korhonen O, Pohja S, Peltonen S, Suihko E, Vidgren M, Paronen P, (2002). Effect of physical properties for starch acetate powders on tableting. AAPS PharmSciTech, 3(4):68–76.
   Google Scholar
• Riepma KA, Veenstra J, de Boer AH, Bolhuis GK, Zuurman IK, Lerk CF, (1991). Consolidation and compaction of powder mixtures: II. Binary mixtures of different particle size fractions of α-lactose. Int J Pharm, 76:9–15.
   Web of Science ®Google Scholar
• Bolhuis GK, Chowhan ZT. (1996). Material for direct compaction. Pharmaceutical powder conpaction technology Swarbrick J. New York, Basel, Hong Kong: Marcel Dekker, Inc; 419–500.
   Google Scholar
• Kuakpetoon D, Flores RA, Milliken GA. (2001). Dry mixing of wheat flours: Effect of particle properties and blending ratio. Lebensm-Wiss u—Technol, 34:183–93.
   Google Scholar
• Gharsallaoui A, Rogé B, Mathlouthi M. (2008). Water-disaccharides interactions in saturated solution and the crystallization conditions. Food Chem, 106:1329–39.
   Web of Science ®Google Scholar
• Machado JJB, Coutinho JA, Macedo EA. (2000). Solid-liquid equilibrium of α-lactose in ethanol/water. Fluid Phase Equilib, 173:121–34.
   Web of Science ®Google Scholar
• Buhler V. (1993). Kollidon®—Polyvinylpyrrolidone for the pharmaceutical industry. Ludwigshafen: BASF.
   Google Scholar
• Bi Y, Mao S, Gan L, Li Y, Ch Wang, Xu N, (2007). A controlled porosity osmotic pump system with biphasic release of theophylline. Chem Pharm Bull, 55(11):1574–80.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. (2007). Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm, 67:211–9.
   PubMed Web of Science ®Google Scholar
• Li F-Q, Hu J-H, Deng J-X, Su H, Xu S, Liu J-Y. (2003). In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm, 324:152–7.
   Google Scholar
• Da-Costa-Pinto EAL, Collares EF. (1997). Chronic lactose intake modifies the gastric emptying of monosaccharides but not of disaccharides in weanling rats. Braz J Med Res, 30:723–6.
   PubMed Web of Science ®Google Scholar
• Guthmann C, Lipp R, Wagner T, Kranz H. (2008). Development of a novel osmotically driven drug delivery system for weakly basic drug. Eur J Pharm Biopharm, 69:667–74.
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface and agitation: I-theoretical consideration. Ind Eng Chem, 23:923–31.
   Google Scholar
• Sood A, Panchagnula R. (1998). Drug release evaluation of diltiazem CR preparations. Int J Pharm, 175:95–107.
   Web of Science ®Google Scholar